Keros Therapeutics Receives $23 million Series B Funding for Development of Therapies to Treat Debilitating Neuromuscular Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2C5VTeQ
via IFTTT